Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.09
Delayed Data
As of Jul 01
 0.00 / 0.00%
Today’s Change
4.02
Today|||52-Week Range
9.27
-6.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash6.0M0.005.5M119.3M
 
 
 
 
Short Term Investment Cash22.2M-11.3M7.0M53.4M
 
 
 
 
 
Cash & Short Term Investments70.1M58.8M65.9M119.3M
 
 
 
 
 
 
ReceivablesReceivables2.4M6.9M2.9M109.0K
 
 
 
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets0.001.7M1.9M2.5M
 
 
 
 
Current Assets72.5M67.5M70.7M121.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross26.1M15.7M14.5M12.4M
 
 
 
 
 
Depreciation-22.1M-12.3M-12.1M-9.8M
 
 
 
 
 
Intangible Assets0.000.0039.1M36.4M
 
 
 
Other Assets0.00150.0K39.1M36.6M
 
 
 
 
Total Assets80.1M76.3M114.5M161.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable309.0K229.0K793.0K1.0M
 
 
 
 
 
Accrued Expenses2.9M3.0M3.6M3.8M
 
 
 
 
 
Other Current Liabilities3.2M4.0M3.7M3.9M
 
 
 
 
 
Other Liabilities6.7M8.7M6.6M6.7M
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes0.00-2.1M-12.3M-11.3M
 
 
 
 
Other Liabilities1.5M1.1M914.0K17.2M
 
 
 
 
 
Total Liabilities8.3M9.7M35.6M36.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity71.8M66.6M79.0M124.9M
 
 
 
 
 
Total Shareholder Equity71.8M66.6M79.0M124.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding33.8M46.6M60.8M69.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account